Citation

Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM, VX16-659-101 Study Group.: VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med, Volume 379 (17), 2018

Authors

Brown C, Davies JC, Horsley A, Mall MA, McKee CM, McKone EF, Moskowitz SM, Plant BJ, Prais D, Ramsey BW, Robertson S, Rowe SM, Shilling RA, Simard C, Taylor-Cousar JL, Tullis E, Uluer A, Van Goor F, VX16-659-101 Study Group., Waltz D, Xuan F, Young T

Journal

N Engl J Med

Year

2018

DOI

10.1056/nejmoa1807119

PubMed

30334693

Machine-readable

REST APIRDF